Wojciech S.
- Country
- Poland
- Department
- n/a
Research Overview
- A Multi-Center Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Systemic Lupus Erythematosus
- Evaluation of Enpatoran Efficacy and Safety in Systemic and Cutaneous Lupus Erythematosus: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of ODM-111 and Paracetamol in the Management of Chronic Pain Associated with Knee Osteoarthritis: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 14 of 95 partner sites.
Specializations
Autoimmune Disorders
Specializes in investigating novel treatments for complex autoimmune conditions, with particular focus on Sjögren's disease and systemic lupus erythematosus. The investigator studies both systemic and cutaneous manifestations of these conditions.
- Sjögren's Disease Management
- Systemic Lupus Treatment
- Cutaneous Lupus Research
Infectious Diseases
Conducts research on therapeutic approaches for various infections, including vulvovaginal candidiasis and COVID-19. Also investigates preventive measures against respiratory syncytial virus infections in older adults.
- Antifungal Therapeutics
- COVID-19 Treatment
- RSV Prevention
Chronic Conditions
Focuses on therapeutic solutions for chronic conditions including chronic spontaneous urticaria, asthma, and osteoarthritis. Particular emphasis on respiratory health and pain management.
- Urticaria Management
- Asthma Treatment
- Chronic Pain Control
Women's Health
Engages in research related to women's health concerns, with emphasis on contraceptive development and reproductive health management. Studies include evaluation of novel delivery systems for contraceptive medications.
- Contraceptive Efficacy
- Reproductive Health
- Drug Delivery Systems
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.